Conversations around women’s health and pharmaceutical accountability are becoming far more urgent across the nation as lawsuits tied to the Depo-Provera birth control shot continue to grow. What ...

Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

DMPA is available in two injectable forms: an intramuscular injection, marketed under the name Depo Provera, that can only be administered by a provider, and one that is injected just under the skin.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Contraception is often used to prevent pregnancies and manage menstrual ...

Too often, some experts say, providers don’t give Medicaid patients extensive options or engage in discussion to reach ...

This week, the FDA approved a label change on Depo Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors known as meningiomas.

Doctors said the meningiomas could be linked to the woman using the contraceptive injections — which she had been receiving regularly for 21 years, in order to avoid getting monthly periods "I'd take ...

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...